Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
YCBD 
cbdMD Inc (YCBD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: YCBD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $2
1 Year Target Price $2
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -43.58% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 10.25M USD | Price to earnings Ratio 2.25 | 1Y Target Price 2 |
Price to earnings Ratio 2.25 | 1Y Target Price 2 | ||
Volume (30-day avg) 1 | Beta 2.43 | 52 Weeks Range 0.59 - 6.54 | Updated Date 10/17/2025 |
52 Weeks Range 0.59 - 6.54 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.51 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -7.96% | Operating Margin (TTM) -19.64% |
Management Effectiveness
Return on Assets (TTM) -9.44% | Return on Equity (TTM) -33.13% |
Valuation
Trailing PE 2.25 | Forward PE 714.29 | Enterprise Value 10420470 | Price to Sales(TTM) 0.54 |
Enterprise Value 10420470 | Price to Sales(TTM) 0.54 | ||
Enterprise Value to Revenue 0.55 | Enterprise Value to EBITDA 63.94 | Shares Outstanding 8912959 | Shares Floating 8757606 |
Shares Outstanding 8912959 | Shares Floating 8757606 | ||
Percent Insiders 16.09 | Percent Institutions 5.48 |
Upturn AI SWOT
cbdMD Inc
Company Overview
History and Background
cbdMD Inc, originally known as Level Brands Inc., was founded in 2015. It rebranded to cbdMD in 2018 to focus on the CBD market. It has grown through product development and acquisitions to become a significant player in the CBD industry.
Core Business Areas
- Human CBD Products: Offers a wide range of CBD products for human consumption including tinctures, capsules, gummies, topicals, and sleep aids.
- Pet CBD Products: Provides CBD products specifically formulated for pets, including tinctures, chews, and topicals.
Leadership and Structure
Martin Sumichrast is the Chairman and CEO. The company has a standard corporate structure with departments for sales, marketing, research & development, and finance.
Top Products and Market Share
Key Offerings
- CBD Tinctures: cbdMD's tinctures are a core product, available in various strengths and flavors. Market share data is not readily available. Competitors include Charlotte's Web (CWBHF), and many smaller private labels. Significant revenue driver for company.
- CBD Gummies: Gummies are another popular product, offering a convenient and palatable way to consume CBD. Market share data is not readily available. Competitors include Charlotte's Web (CWBHF), and many smaller private labels. Significant revenue driver for company.
- CBD Topicals: cbdMD offers creams, balms, and lotions infused with CBD for targeted relief. Market share data is not readily available. Competitors include Charlotte's Web (CWBHF), and many smaller private labels.
Market Dynamics
Industry Overview
The CBD industry is experiencing rapid growth, driven by increasing consumer awareness and acceptance of CBD's potential health benefits. However, the market is fragmented and subject to evolving regulations.
Positioning
cbdMD Inc. positions itself as a premium CBD brand with a focus on quality and transparency. They aim to differentiate through product innovation and strong branding.
Total Addressable Market (TAM)
Estimates for the global CBD market vary, but projections often exceed $10 billion. cbdMD is a small player, though poised to grow through strategic branding and market execution.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Wide product range
- Focus on quality
- Strong online presence
Weaknesses
- Limited profitability
- Dependence on online sales channels
- Susceptibility to regulatory changes
- High marketing costs
Opportunities
- Expansion into new markets
- Development of new products
- Partnerships with retailers
- Increased regulatory clarity
Threats
- Intense competition
- Evolving regulations
- Negative publicity
- Price wars
Competitors and Market Share
Key Competitors
- CWBHF
- SMG
- TLRY
Competitive Landscape
cbdMD faces intense competition from larger, more established companies as well as numerous smaller players. Differentiating its brand and maintaining quality are key to its success. The market is highly fragmented, with low barrier to entry.
Major Acquisitions
Pawasol GmbH
- Year: 2021
- Acquisition Price (USD millions): 6
- Strategic Rationale: Acquisition expanded cbdMD's international presence, particularly in Europe. Pawasol is a pet care brand
Growth Trajectory and Initiatives
Historical Growth: cbdMD experienced rapid initial growth followed by challenges in maintaining profitability.
Future Projections: Future projections depend on market conditions and the company's ability to execute its strategy.
Recent Initiatives: Recent initiatives include new product launches and marketing campaigns.
Summary
cbdMD Inc. has established a brand in the competitive CBD market, but faces significant challenges. While its product range and online presence are strengths, profitability, regulatory uncertainty, and intense competition pose threats. Success hinges on strategic expansion, product innovation, and adapting to the evolving regulatory landscape. The company is fighting for market share against larger players, with recent initiatives focused on brand awareness.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Market Analysis Reports
Disclaimers:
This analysis is based on available information and is not financial advice. The CBD industry is rapidly evolving, and results may vary. Market share data is based on estimates.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About cbdMD Inc
Exchange NYSE MKT | Headquaters Charlotte, NC, United States | ||
IPO Launch date 2019-04-29 | Interim CEO, CFO, Principal Executive Officer & Director Mr. T. Ronan Kennedy | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 42 | Website https://www.cbdmd.com |
Full time employees 42 | Website https://www.cbdmd.com | ||
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.